Atıf Formatları
The impact of smoking on nivolumab outcomes in renal cell carcinoma: Real-world data from the Turkish Oncology Group Kidney Cancer Consortium
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

E. Sertesen Camoz Et Al. , "The impact of smoking on nivolumab outcomes in renal cell carcinoma: Real-world data from the Turkish Oncology Group Kidney Cancer Consortium," Oncologist , vol.30, no.7, 2025

Sertesen Camoz, E. Et Al. 2025. The impact of smoking on nivolumab outcomes in renal cell carcinoma: Real-world data from the Turkish Oncology Group Kidney Cancer Consortium. Oncologist , vol.30, no.7 .

Sertesen Camoz, E., BÖLEK, H., Kuzu, O. F., Sim, S., Karakaş, H., Sekmek, S., ... Guliyev, M.(2025). The impact of smoking on nivolumab outcomes in renal cell carcinoma: Real-world data from the Turkish Oncology Group Kidney Cancer Consortium. Oncologist , vol.30, no.7.

Sertesen Camoz, Elif Et Al. "The impact of smoking on nivolumab outcomes in renal cell carcinoma: Real-world data from the Turkish Oncology Group Kidney Cancer Consortium," Oncologist , vol.30, no.7, 2025

Sertesen Camoz, Elif S. Et Al. "The impact of smoking on nivolumab outcomes in renal cell carcinoma: Real-world data from the Turkish Oncology Group Kidney Cancer Consortium." Oncologist , vol.30, no.7, 2025

Sertesen Camoz, E. Et Al. (2025) . "The impact of smoking on nivolumab outcomes in renal cell carcinoma: Real-world data from the Turkish Oncology Group Kidney Cancer Consortium." Oncologist , vol.30, no.7.

@article{article, author={Elif Sertesen Camoz Et Al. }, title={The impact of smoking on nivolumab outcomes in renal cell carcinoma: Real-world data from the Turkish Oncology Group Kidney Cancer Consortium}, journal={Oncologist}, year=2025}